Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Cybin Corp.

MissionIRNewsBreaks – Cybin Corp. CEO Discusses Milestones, Goals and Momentum in Exciting Emerging Industry

Posted on September 15, 2020 by MissionIR

Cybin, a life-sciences company focused on advancing psychedelic and nutraceutical-based products, today announced that its CEO, Doug Drysdale, is featured in an exclusive audio interview with NetworkNewsWire (“NNW”) – a financial news and content distribution company and one of 50+ … Continue reading →

Posted in Cybin Corp., MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Cybin Corp. Focused on Advancing New Products Amid Positive Research in Psychedelics

Posted on September 11, 2020 by MissionIR

Cybin Corp., an exemplary Canada-based, life-science company focused on the development of pharmaceutical-grade psilocybin products, is at the forefront of change in an era open to exploring psychedelic treatment options where big pharma has failed. Started in the 1940s, but … Continue reading →

Posted in Cybin Corp. | Leave a comment

MissionIRNewsBreaks — Cybin Corp. Names Health-Care, M&A Expert as New Chief Executive Officer

Posted on September 1, 2020 by MissionIR

Cybin Corp., a life-sciences company advancing psychedelic pharmaceuticals, has announced that Doug Drysdale has been appointed as CEO. With more than three decades of experience, Drysdale brings invaluable insight and expertise to his new role. In 2014 as a corporate … Continue reading →

Posted in Cybin Corp., MissionIRNewsBreaks | Leave a comment

Cybin Corp. at Forefront of Change in Psilocybin-Based Treatments

Posted on August 31, 2020 by MissionIR

Company focused on furthering R&D of psilocybin-based medications Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain Psilocybin shows promise for an array of mental health issues Cybin Corp. is a leading life-science company focused on … Continue reading →

Posted in Cybin Corp. | Leave a comment

MissionIRNewsBreaks – Cybin Corp. Poised Amid Groundbreaking Decision to Allow Psilocybin Therapy

Posted on August 26, 2020 by MissionIR

Cybin Corp., an exemplary Canada-based life-science company focused on the development of pharmaceutical-grade psilocybin products, appears ideally positioned to leverage a milestone moment. Canada’s Minister of Health, the Honourable Patty Hajdu, recently approved the use of psilocybin therapy in the … Continue reading →

Posted in Cybin Corp. | Leave a comment

MissionIRNewsBreaks – Cybin Corp. Partners with IntelGenx to Develop Efficient Delivery Method for Pharmaceutical-Grade Psilocybin

Posted on August 19, 2020 by MissionIR

Cybin Corp. recently announced its entry into a feasibility agreement with IntelGenx Corp., a leading drug-delivery company focused on the development and manufacturing of pharmaceutical delivery films (http://ibn.fm/TZeVy). Under the agreement, the two companies will collaborate to develop an orally dissolving, … Continue reading →

Posted in Cybin Corp. | Leave a comment

Cybin Corp. Ideally Positioned as Landmark Decision Regarding Psilocybin Therapy Could Spark Increased Interest, Use

Posted on August 19, 2020 by MissionIR

Canada’s Minister of Health approves the use of psilocybin therapy in end-of-life care of four Canadians battling incurable cancer The Decision marks first legal, medical exemptions for psilocybin use in Canada since the compound became illegal in 1974 Cybin subsidiary … Continue reading →

Posted in Cybin Corp. | Leave a comment

Cybin Corp. Enters Feasibility Agreement to Develop Fast-Acting Psilocybin Film

Posted on August 17, 2020 by MissionIR

Agreement with leading drug-delivery company outlines plans to develop fast-acting, orally dissolving film for delivery of pharmaceutical-grade psilocybin Cybin CEO notes that systemic bioavailability of film is projected to be high Cybin focused on developing fungi-derived psychedelic, medicinal products to … Continue reading →

Posted in Cybin Corp. | Leave a comment

MissionIRNewsBreaks — Cybin Calls Approval for Psilocybin Therapy in Palliative Care Treatment a ‘Watershed Moment’

Posted on August 7, 2020 by MissionIR

Cybin Corp., Canada’s leading-edge mushroom life-sciences company, has noted its strong support for TheraPsil, a nonprofit coalition that advocates for legal, Special Access Programme (“SAP”) access to psilocybin therapy for palliative care of Canadians. The coalition recently announced that Federal … Continue reading →

Posted in Cybin Corp., MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Cybin Corp. Positioned in Shifting Trend Toward Psilocybin

Posted on August 5, 2020 by MissionIR

Cybin Corp., Canada’s premier mushroom life-sciences company focused on advancing psychedelic and nutraceutical-based products, looks to be at the right place at the right time during a shifting trend toward psilocybin. Highlighting this shift, TheraPsil, a non-profit coalition that advocates … Continue reading →

Posted in Cybin Corp., MissionIRNewsBreaks | Leave a comment